AI assistant
Sending…
ARVINAS, INC. — Director's Dealing 2024
Mar 21, 2024
32625_dirs_2024-03-21_ee6a7a03-e840-41b5-af53-a5ed244ccc8b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ARVINAS, INC. (ARVN)
CIK: 0001655759
Period of Report: 2024-03-18
Reporting Person: Berkowitz Noah (Chief Medical Officer)
More from ARVINAS, INC.
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 1
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 20
Regulatory Filings
2026
Mar 18
Director's Dealing
2026
Mar 3